Gilmartin Group

What Gilmartin Group does

Gilmartin Group is a healthcare-only strategic advisory and investor relations firm founded in 2018 and headquartered in Larkspur, California, with additional offices in New York and San Diego. The firm serves over 100 healthcare innovators across five verticals — MedTech, Biotechnology, Digital Health, Life Science Tools & Diagnostics, and Healthcare Services — providing a comprehensive suite of advisory services spanning investor relations, IPO and capital markets advisory, strategy and business development consulting, ESG advisory, KOL/analyst education, shareholder engagement, presentation creation, and perception audits. Its go-to-market is sales-led and direct, leveraging conference participation (notably the J.P. Morgan Healthcare Conference), vertical-specific newsletters, webinars, and a downloadable resource library to generate inbound demand from healthcare company executives, boards, and IR teams.

Gilmartin's commercial model is professional services, generating revenue from a mix of recurring advisory retainers and transaction-based IPO advisory fees. The firm claims to have served as strategic advisor on approximately 70% of growth MedTech IPOs (minimum $50M raise) over the last six years, and has been engaged on recent marquee mandates including Ceribell's $207M IPO (October 2024) — the first growth MedTech IPO since October 2021 — and Kestra Medical's $232M IPO (March 2025). The firm is privately held, founder-led by CEO Lynn Lewis, and operates without external institutional capital or a parent company.

Leadership includes Founder & CEO Lynn Lewis and Managing Directors Brian Johnston (New York), Stephen Jasper (Biotech), Ryan Halsted (Digital Health/HCIT), David Deuchler (Diagnostics/regulatory), and Laurence Watts (Biotech), supported by a Head of ESG Advisory and two Principals. The firm does not develop proprietary technology and its competitive moat rests on healthcare domain specialization, sector-specific talent, and an established track record in MedTech capital markets rather than on any productized platform or AI capabilities.

Name

Gilmartin Group

Legal name

Gilmartin Group LLC

Website

https://gilmartinir.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Gilmartin Group is a healthcare-only strategic advisory and investor relations firm serving 100+ MedTech, Biotech, Digital Health, Life Science Tools & Diagnostics, and Healthcare Services clients with IR, IPO advisory, ESG, and shareholder engagement services from offices in Larkspur, New York, and San Diego.

Ownership category

akta.pro rank

Product category

Healthcare Investor Relations Advisory

NAICS

Portfolio Management and Investment Advice (523940), Other Management Consulting Services (541618)

SIC

Services-Management Consulting Services (8742), Investment Advice (6282)

akta.pro primary industry

Corporate Finance & Capital Advisory (BPAHADAB)

akta.pro secondary industries

Industry-Specialist / Sector-Focused M&A Advisory (FSAEAGAJ), Corporate Strategy Advisory (BPAHADAA)

Keywords

• Investor relations advisory
• IPO advisory services
• Capital markets consulting
• Healthcare strategic advisory
• Shareholder engagement services

Headquarters

HQ city

Larkspur

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Investor Relations Advisory Services: Recurring advisory retainers and project-based fees for investor relations consulting services to healthcare companies including messaging development, investor targeting, earnings preparation, and shareholder engagement.
2. IPO Advisory and Capital Markets Services: Transaction-based fees and advisory retainers for IPO preparation support, including S-1 drafting assistance, syndicate advisory, roadshow preparation, and capital markets strategy.
3. Strategy and Consulting: Advisory fees for business development strategy, perception audits, KOL/analyst education, and presentation creation services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Gilmartin Group is a healthcare-focused strategic advisory and investor relations firm that helps emerging healthcare technology companies create durable shareholder value. Its core offerings include Investor Relations, IPO & Capital Markets Advisory, Strategy & Business Development Consulting, ESG Advisory, KOL/Analyst Education, Shareholder Engagement, Presentation Creation, and Perception Audit services delivered to MedTech, Biotech, Digital Health, Life Science Tools & Diagnostics, and Healthcare Services clients.

Product overview

Gilmartin Group operates as a strategic advisory and investor relations firm focused exclusively on the healthcare sector. The firm offers a comprehensive suite of advisory services organized around core IR functions: investor relations, IPO and capital markets advisory, strategy and business development consulting, ESG advisory, KOL/analyst education, shareholder engagement, presentation creation, and perception audit services. The firm also provides educational resources including bi-weekly, monthly, and quarterly newsletters across Biotech, MedTech, Life Science Tools & Diagnostics, and Digital Health/HCIT sectors, as well as downloadable guides on going public and investor presentations. These services are designed to help emerging healthcare technology companies build institutional investor relationships and communicate complex clinical and regulatory narratives with precision and credibility.

Differentiator

Problem solved

Functional benefit

Products and services

• Investor Relations Strategic advisory services focused on creating durable shareholder value for healthcare companies, including investor targeting, relationship development, and messaging strategy.
• IPO & Capital Markets Advisory Comprehensive support for healthcare companies preparing for and executing IPOs and capital markets transactions, including S-1 drafting assistance, syndicate advisory, roadshow preparation, and going-public guidance.
• Strategy & Business Development Consulting Advisory services helping healthcare companies prioritize corporate resources to maximize value, including FP&A support and guidance strategy.
• ESG Advisory Services empowering healthcare companies to navigate sustainability efforts and ESG disclosure requirements with confidence.
• KOL/Analyst Education Outreach, presentation, and organizational support for KOL (key opinion leader) meetings and analyst engagements for healthcare companies.
• Shareholder Engagement Innovative and efficient approaches to drive investor engagement through conference management, non-deal roadshows, and shareholder analysis.
• Presentation Creation Development of compelling messaging and engaging graphics to effectively communicate value propositions for investor presentations.
• Perception Audit Services to evaluate overall perception and run diligence to obtain market sentiments through financial community perception surveys.

Named customers16 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• ICR Healthcare (Westwicke): ICR Healthcare (formerly Westwicke Partners) is a leading healthcare-focused investor relations and strategic advisory firm serving MedTech, Biotech, and Life Sciences issuers. It is the closest large-scale direct competitor to Gilmartin, competing for the same healthcare IPO advisory and ongoing IR mandates.
• LifeSci Advisors: LifeSci Advisors is a healthcare-exclusive investor relations and capital markets advisory firm serving biotech, MedTech, and life sciences clients globally. It is a direct peer given its analogous healthcare-only positioning, IPO advisory work, and ongoing IR retainer model.
• Burns McClellan: Burns McClellan is a healthcare-focused investor relations and strategic communications firm specializing in biotech, MedTech, and life sciences. It is comparable to Gilmartin in its sector exclusivity and IR advisory service model.
• Argot Partners: Argot Partners is a healthcare-specialized investor relations and strategic communications advisory firm serving biotech, MedTech, and pharma clients. It competes head-to-head with Gilmartin for IR retainers and IPO advisory engagements in the healthcare vertical.
• Rx Communications Group: Rx Communications Group is a healthcare-focused investor relations firm serving biotech and emerging pharma issuers. It is a direct competitor in the healthcare IR retainer and capital markets advisory space.
• Solebury Trout: Solebury Trout (now part of the broader Solebury group) provides healthcare-focused investor relations, capital markets advisory, and equity research distribution. It competes with Gilmartin for healthcare IPO advisory and ongoing IR mandates, with similar sub-sector coverage.
• Lazar Partners: Lazar Partners is a healthcare-focused investor relations and strategic communications firm serving biotech, MedTech, and pharma clients. It is comparable to Gilmartin in its vertical specialization and advisory service mix.

Broad incumbents

• Addo Investor Relations: Addo Investor Relations is a broader IR and strategic communications firm with a healthcare practice alongside consumer, tech, and other verticals. It is a comparable peer given its overlapping IR advisory model, though less exclusively focused on healthcare than Gilmartin.
• Goldman Sachs Healthcare Investment Banking: Goldman Sachs' healthcare investment banking group is a bulge-bracket lead bookrunner on healthcare IPOs. It represents a broader incumbent that competes with Gilmartin on the largest healthcare IPO mandates, though it offers a far wider service portfolio and execution scale.
• Cowen (TD Cowen) Healthcare: TD Cowen has a historically strong healthcare equity capital markets and IR advisory franchise with deep MedTech and biotech coverage. It competes with Gilmartin for healthcare IPO mandates and ongoing investor relations advisory at the larger end of the market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/gilmartin-group-llc
• Xx.com/gilmartinir

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gilmartin Group